Immediate Impact
1 by Nobel laureates 1 from Science/Nature 57 standout
Citing Papers
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways
2025 Standout
Works of Tabea Erdmann being referenced
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma
2022
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Tabea Erdmann | 104 | 190 | 67 | 83 | 14 | 334 | |
| C. Man | 61 | 199 | 36 | 43 | 16 | 349 | |
| Jeffrey C. Xing | 94 | 174 | 77 | 68 | 14 | 339 | |
| Svetlana Harder | 172 | 93 | 94 | 55 | 13 | 272 | |
| Jacek Marzec | 60 | 213 | 57 | 40 | 16 | 331 | |
| Julie Agopian | 153 | 72 | 104 | 106 | 13 | 289 | |
| Ana Inés Landoni | 77 | 189 | 128 | 122 | 17 | 324 | |
| Linden Lyne | 66 | 210 | 19 | 72 | 15 | 358 | |
| Ajanthah Sangaralingam | 76 | 174 | 37 | 52 | 17 | 346 | |
| Matias Autio | 172 | 108 | 32 | 85 | 18 | 310 | |
| M Collyn-d'Hooghe | 118 | 165 | 92 | 69 | 15 | 363 |
All Works
Login with ORCID to disown or claim papers
Loading papers...